Related Experiment Video
Updated: Feb 17, 2026

Whole-Body Nanoparticle Aerosol Inhalation Exposures
Published on: May 7, 2013
Medical Monitoring for Occupational Asthma Among Toluene Diisocyanate Production Workers in the United States
Laura D Cassidy1, Brent Doney, Mei Lin Wang
1Medical College of Wisconsin, Milwaukee, Wisconsin (Dr Cassidy); National Institute for Occupational Safety and Health, Morgantown, West Virginia (Drs Doney, Wang, Kurth, Storey); BASF-The Chemical Company, Florham Park, New Jersey (Dr Conner); DOW Chemical Company, Midland, Michigan (Drs Collins, Carson); Saginaw Valley State University, University City, Michigan (Dr Collins); Covestro LLC (formerly Bayer MaterialScience LLC), Pittsburgh, Pennsylvania (Dr Molenaar); and Yale University School of Medicine, New Haven, Connecticut (Dr Redlich).
Objective:
The aim of this study was to describe a study of medical monitoring methods and lessons learned in detecting health outcomes in U.S. plants producing toluene diisocyanate (TDI).
Methods:
A multidisciplinary team implemented a medical and environmental monitoring program in three TDI plants.
Results:
Of 269 eligible workers, 197 (73%) participated and 42 (21%) met symptom and/or lung function criteria that would trigger evaluation for possible asthma over 5 years of data collection. Subsequent evaluation was delayed for most, and a web-based data collection system improved timeliness.
Conclusion:
Medical monitoring of TDI workers identified workers triggering further assessment per study protocol. Systems and/or personnel to ensure rapid follow-up are needed to highlight when triggering events represent potential cases of asthma needing further evaluation. Implementation of a research protocol requires resources and oversight beyond an occupational health program.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Therapeutic Drug Monitoring: Drug Analysis Methods
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

